FDA Accepts Supplement for ADRENALIN (Epinephrine) NDA204640
The FDA has accepted a supplemental application for ADRENALIN, which contains epinephrine as the active ingredient.
Asset / Drug
Drug and asset intelligence for ADRENALIN with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.